Immune related therapies are growing in cancer care as modern treatments utilize our own systems to attack the disease. This also means we will see growing numbers of these patients in the emergency department with complications from these interventions. We chat with Dr. Chris Coyne who is "geeking out" about the technology and our role in EM.

This episode was supported by an unrestricted grant from Bristol Myers Squibb and AstraZeneca Pharmaceutical for the Recognition and Management of Immune Related Adverse Events.